methazolamide and pyruvic acid

methazolamide has been researched along with pyruvic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrikopoulos, S; Connor, T; Cooper, A; de Vries, M; Fahey, R; Foletta, VC; Garcia-Guerra, L; Jones, S; Konstantopoulos, N; Krippner, G; McGee, SL; Molero, JC; Morrison, S; Spolding, B; Swinton, C; Walder, KR; Wanyonyi, S1

Other Studies

1 other study(ies) available for methazolamide and pyruvic acid

ArticleYear
Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.
    Diabetes, 2012, Volume: 61, Issue:8

    Topics: Animals; Blood Glucose; Carbonic Anhydrase Inhibitors; Diabetes Mellitus, Experimental; Glucose Clamp Technique; Glucose-6-Phosphatase; Glycolysis; Homeostasis; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Metformin; Methazolamide; Mice; Mice, Inbred C57BL; Mice, Obese; Oxygen Consumption; Phosphoenolpyruvate Carboxykinase (ATP); Pyruvic Acid; Rats; Rats, Sprague-Dawley

2012